Back to search results

VS-6766+Abema+Fulv in Met HR+/HER- BC

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Breast Cancer · Hormone Receptor-positive Breast Cancer · Hormone Receptor Positive HER-2 Negative Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

  • Brigham and Women's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Adrienne G Waks, MD) · awaks@partners.org · 617-632-3800
    Contact: Principal Investigator (Adrienne G Waks, MD)

  • Dana Farber Cancer Institite, Boston, Massachusetts, United States

    Contact: Study coordinator (Adrienne G Waks, MD) · awaks@partners.org · 617-632-3800
    Contact: Principal Investigator (Adrienne G Waks, MD)
Study leads

  • Adrienne G Waks, MD

    Principal Investigator

    Dana-Farber Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)